Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Angiogenesis factors involved in the pathogenesis of colorectal cancer.

Mihalache A, Rogoveanu I.

Curr Health Sci J. 2014 Jan;40(1):5-11. doi: 10.12865/CHSJ.40.01.01. Review.

2.

Clinical meaning of BRAF mutation in Korean patients with advanced colorectal cancer.

Kim B, Park SJ, Cheon JH, Kim TI, Kim WH, Hong SP.

World J Gastroenterol. 2014 Apr 21;20(15):4370-6. doi: 10.3748/wjg.v20.i15.4370.

3.

Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer.

Lahera T, Calvo A, Torres G, Rengifo CE, Quintero S, Arango Mdel C, Danta D, Vázquez JM, Escobar X, Carr A.

J Oncol. 2014;2014:482301. doi: 10.1155/2014/482301.

4.

Review of histopathological and molecular prognostic features in colorectal cancer.

Marzouk O, Schofield J.

Cancers (Basel). 2011 Jun 23;3(2):2767-810. doi: 10.3390/cancers3022767.

5.
6.

The role of personalized medicine in metastatic colorectal cancer: an evolving landscape.

Moorcraft SY, Smyth EC, Cunningham D.

Therap Adv Gastroenterol. 2013 Sep;6(5):381-95. doi: 10.1177/1756283X13491797.

7.

Lifestyle factors associated with survival after colorectal cancer diagnosis.

Boyle T, Fritschi L, Platell C, Heyworth J.

Br J Cancer. 2013 Aug 6;109(3):814-22. doi: 10.1038/bjc.2013.310.

8.

Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients.

Lee SJ, Choi SY, Kim WJ, Ji M, Lee TG, Son BR, Yoon SM, Sung R, Lee EJ, Youn SJ, Park SM.

Diagn Pathol. 2013 Jun 19;8:99. doi: 10.1186/1746-1596-8-99.

9.

Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women.

Samadder NJ, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, Lynch CF, Anderson KE, French AJ, Haile RW, Potter JD, Slager SL, Smyrk TC, Thibodeau SN, Cerhan JR, Limburg PJ.

Gastroenterology. 2013 Aug;145(2):348-56.e1-2. doi: 10.1053/j.gastro.2013.05.001.

10.

MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness?

Caruso S, Bazan V, Rolfo C, Insalaco L, Fanale D, Bronte G, Corsini LR, Rizzo S, Cicero G, Russo A.

Oncogenesis. 2012 Nov 12;1:e32. doi: 10.1038/oncsis.2012.33.

11.

Correlations of dynamic contrast-enhanced magnetic resonance imaging with morphologic, angiogenic, and molecular prognostic factors in rectal cancer.

Hong HS, Kim SH, Park HJ, Park MS, Kim KW, Kim WH, Kim NK, Lee JM, Cho HJ.

Yonsei Med J. 2013 Jan 1;54(1):123-30. doi: 10.3349/ymj.2013.54.1.123.

12.

IgG expression in human colorectal cancer and its relationship to cancer cell behaviors.

Niu N, Zhang J, Huang T, Sun Y, Chen Z, Yi W, Korteweg C, Wang J, Gu J.

PLoS One. 2012;7(11):e47362. doi: 10.1371/journal.pone.0047362.

13.

The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study.

Gormley JA, Hegarty SM, O'Grady A, Stevenson MR, Burden RE, Barrett HL, Scott CJ, Johnston JA, Wilson RH, Kay EW, Johnston PG, Olwill SA.

Br J Cancer. 2011 Nov 8;105(10):1487-94. doi: 10.1038/bjc.2011.408.

14.

Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival.

Birgisson H, Wallin U, Holmberg L, Glimelius B.

BMC Cancer. 2011 Oct 11;11:438. doi: 10.1186/1471-2407-11-438.

16.
17.

Cell surface markers in colorectal cancer prognosis.

Belov L, Zhou J, Christopherson RI.

Int J Mol Sci. 2010 Dec 28;12(1):78-113. doi: 10.3390/ijms12010078. Review.

18.

A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.

Deschoolmeester V, Baay M, Specenier P, Lardon F, Vermorken JB.

Oncologist. 2010;15(7):699-731. doi: 10.1634/theoncologist.2010-0025. Review.

19.

Upregulation of SPRR3 promotes colorectal tumorigenesis.

Cho DH, Jo YK, Roh SA, Na YS, Kim TW, Jang SJ, Kim YS, Kim JC.

Mol Med. 2010 Jul-Aug;16(7-8):271-7. doi: 10.2119/molmed.2009.00187.

20.

Two-marker protein profile predicts poor prognosis in patients with early rectal cancer.

Zlobec I, Baker K, Terracciano L, Peter S, Degen L, Beglinger C, Lugli A.

Br J Cancer. 2008 Nov 18;99(10):1712-7. doi: 10.1038/sj.bjc.6604729.

Items per page

Supplemental Content

Support Center